Abstract: Impact Therapeutics raised HKD 759m (USD 97m) from its global offering and will list on the Hong Kong Stock Exchange on Friday, May 15th, 2026. In our previous note, we looked at the company's fundamentals and the valuation. In this note, we provide an update for the IPO before its trading debut.
GENFLEET, LEADS BIOLABS, IMPACT THERAP
Interested in the full report? Get in touch with our team.